CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Stellar Science Solving Cancer and COVID-19

    CRI Lloyd J. Old STARs are contributing to immunology work to combat COVID-19.

    August 27, 2020| Alice Northover
  • Medical Technology to Fight Cancer and COVID-19

    CRI Technology Impact Award recipients are adapting technologies developed for cancer immunotherapies to understand and treat COVID-19….

    August 26, 2020| Alice Northover
  • Translating Cancer Immunotherapy Into COVID-19 Medicine

    Investigators in CRI’s translational research program (CLIP) were quick to extend their cancer immunotherapy research into COVID-19…

    August 25, 2020| Alice Northover
  • Young Researchers Finding Answers to Cancer and COVID-19

    Many CRI Irvington Postdoctoral Fellows pivoted their work, offered their expertise, volunteered their time, and have already…

    August 24, 2020| Alice Northover
  • Funding Basic Research to Build a Better Future

    Supporting young scientists whose research on the fundamentals of our immune system and its relationship to cancer…

    August 18, 2020| Arthur N. Brodsky, PhD
  • Immunotherapy is Here to Stay: Looking Back at this Year’s Breakthroughs

    Important immunotherapy breakthroughs benefited patients immensely in 2017 and paved the way for even more advances in…

    December 28, 2017| Arthur N. Brodsky, PhD
  • CRI Researcher Highlights New Technique to Aid Immunotherapy

    Dr. Mohammad Rashidian’s nanobodies could help improve doctors’ decisions regarding immunotherapy.

    October 26, 2017| Arthur N. Brodsky, PhD
  • CRI Awards $29.3 Million to Fund Immunotherapies for All Kinds of Cancer

    CRI committed new funds to accelerate research and clinical development.

    August 6, 2015| Alexandra Mulvey

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute